Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 310-060-2 | CAS number: 102110-59-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented study report which meets basic scientific principles. Read-across to silicates (major components of the slag).
Data source
Reference
- Reference Type:
- publication
- Title:
- Pharmacokinetic study of Zeolite A, sodium aluminosilicate, magnesium silicate, and aluminium hydroxide in dogs
- Author:
- Cefali E.A, Nolan J.C, McConnell W.R and Lowe Walters D.
- Year:
- 1 995
- Bibliographic source:
- Pharm Res 12, 270-274
Materials and methods
- Objective of study:
- absorption
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Beagle dogs were given oral doses of sodium aluminosilicate, magnesium silicate, aluminium hydroxide and Zeolite A (an aluminium silicate) and the plasma silicon and aluminium concentrations were followed for 24 h.
- GLP compliance:
- no
Test material
- Reference substance name:
- sodium aluminiumsilicate
- IUPAC Name:
- sodium aluminiumsilicate
- Reference substance name:
- magnesium trisilicate
- IUPAC Name:
- magnesium trisilicate
- Reference substance name:
- Zeolite A (an aluminium silicate)
- IUPAC Name:
- Zeolite A (an aluminium silicate)
- Reference substance name:
- Aluminium hydroxide
- EC Number:
- 244-492-7
- EC Name:
- Aluminium hydroxide
- Cas Number:
- 21645-51-2
- IUPAC Name:
- aluminum trihydroxide
- Details on test material:
- Sodium aluminosilicate lot #SR00002922
Magnesium trisilicate lot #BD203
Zeolite A (N-0974) raw material (Ethyl, lot #07)
Concentrated aluminium hydroxide gel, 675 mg/5 ml (lot #911187)
Constituent 1
Constituent 2
Constituent 3
Constituent 4
- Radiolabelling:
- no
Test animals
- Species:
- dog
- Strain:
- Beagle
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: No data
- Age at study initiation: 10-13 months
- Weight at study initiation: 7.3-11.6 kg
- Fasting period before study: no data
- Housing: individually in stainless steel cages
- Individual metabolism cages: no
- Diet (e.g. ad libitum): diet available for ca 3 h per day, provided ca 4 h after dosing
- Water (e.g. ad libitum): ad libitum
- Acclimation period: no dara
ENVIRONMENTAL CONDITIONS
- Environmentally controlled room; no other data
IN-LIFE DATES: animals not sacrficed
Administration / exposure
- Route of administration:
- oral: capsule
- Vehicle:
- unchanged (no vehicle)
- Duration and frequency of treatment / exposure:
- The animals received a single dose of each test substance. The exposures were carried out with one-week intevals in-between.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Sodium aluminosilicate 16 mg/kg (capsule)
Magnesium trisilicate 20 mg/kg (capsule)
Zeolite A 30 mg/kg (capsule)
Aluminium hydroxide gel 675 mg/animal in 5 ml (orally by gavage)
- No. of animals per sex per dose / concentration:
- 12 (the same animals were used for all tests)
- Control animals:
- yes, historical
- Positive control reference chemical:
- No
- Details on study design:
- Dosing of the different test substances was carried out in a randomized, 4-way crossover design.
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: blood
- Time and frequency of sampling: 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 h after dosing - Statistics:
- One-way ANOVA used for comparison of AUC values and Tmax values.
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Mean plasma silicon AUC values, Cmax and Tmax are presented in table 1. Although mean silicon AUC and Cmax values were elevated when compared to baseline, only the AUC from Zelite A was statsitically significantly increased. The Cmax and Tmax values were not significantly different.
There were no significant differences in aluminium absorption from the different substances, although the aluminium concentration in the samples varied. The results are presented in table 2.
Any other information on results incl. tables
Table 1. Silicon bioavailaibility estimates | ||||
Zeolite A | Sodium aluminosilicate | Magnesium trisilicate | Aluminium hydroxide | |
Silicon dose (mg/kg) | 4,66 | 4,75 | 4,63 | 0 |
Cmax (mg/l) | 1.07 ± 1.06 | 0.67 ± 0.27 | 0.75 ± 0.31 | 0.44 ± 0.17 |
AUC (mg*h/l) | 9.5 ± 4.5 | 7.7 ± 1.6 | 8.8 ± 3.0 | 6.1 ± 1.9 |
Tmax (h) | 7.9 ± 6.4 | 5.8 ± 4.6 | 6.9 ± 6.3 | 8.5 ± 3.4 |
Table 2. Aluminium bioavailaibility estimates | ||||
Zeolite A | Sodium aluminosilicate | Magnesium trisilicate | Aluminium hydroxide | |
Aluminium dose (mg/kg) | 3,36 | 0,9 | 0 | 28 |
Cmax (µg/l) | 29 ± 9 | 27 ± 14 | 24 ± 5 | 29 ± 11 |
AUC (µg*h/l) | 342 ± 111 | 338 ± 167 | 315 ± 69 | 355 ± 150 |
Tmax (h) | 3.5 ± 4.1 | 4.2 ± 4.3 | 5.7 ± 7.3 | 5.0 ± 4.7 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): other: Silicon was absorbed from the different silicates after single oral administration in dogs. Zeolite A was the only test substane which demonstarted a significantly higher absorption than any other treatment or baseline. No statistically significant absor
Silicon was absorbed from the different silicates after single oral administration in dogs. Zeolite A was the only test substane which demonstrated a significantly higher absorption than any other treatment or baseline. No statistically significant absorption of aluminium occurred. - Executive summary:
Cefali et al. (1995): Beagle dogs were given oral doses of sodium aluminosilicate, magnesium silicate, aluminium hydroxide and Zeolite A (an aluminium silicate), and the plasma silicon and aluminium concentrations were followed for 24 h. Silicon was absorbed from the different silicates after a single oral administration in dogs. However, Zeolite A was the only test substance which demonstrated a significantly higher absorption than any other treatment or baseline. No statistically significant absorption of aluminium occurred.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.